Format

Send to:

Choose Destination
See comment in PubMed Commons below
Am J Obstet Gynecol. 2009 Dec;201(6):579.e1-8. doi: 10.1016/j.ajog.2009.06.061. Epub 2009 Aug 18.

Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.

Author information

  • 1Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington School of Public Health and Community Medicine, Seattle, WA 98101, USA. ronitc@u.washington.edu

Abstract

OBJECTIVE:

The purpose of this study was to determine the association of maternal psychotropic medication use during pregnancy with preterm delivery and other adverse perinatal outcomes.

STUDY DESIGN:

A cohort of 2793 pregnant women in Washington State was interviewed, and their medical files were abstracted. Logistic regression models were constructed to assess odds ratios for perinatal outcomes by use of psychotropic medications.

RESULTS:

Maternal use of benzodiazepine during pregnancy was associated with an increased risk of preterm delivery (adjusted odds ratio, 6.79; 95% confidence interval, 4.01-11.5) and with increased risks of low birthweight, low Apgar score, neonatal intensive care unit admissions, and respiratory distress syndrome. Selective serotonin receptor inhibitors were associated with preterm deliveries only among women who started treatment after the first trimester.

CONCLUSION:

Benzodiazepine was associated highly with preterm delivery and other adverse perinatal outcomes. Well-conducted cohort studies are warranted to draw conclusions about risks and benefits of psychotropic medication use during pregnancy.

PMID:
19691950
[PubMed - indexed for MEDLINE]
PMCID:
PMC2881461
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk